Skip to main content
大唐药业 logo

大唐药业 — Investor Relations & Filings

Ticker · 920433 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 420 across all filing types
Latest filing 2022-05-23 Director's Dealing
Country CN China
Listing Beijing Stock Exchange 920433

About 大唐药业

http://www.nmdt.com.cn/

Inner Mongolia Datang Pharmaceutical specializes in the research, development, and production of traditional Chinese and Mongolian medicines. The company focuses on modernizing ethnic medicinal formulas through advanced biotechnology and standardized manufacturing processes. Its product portfolio covers therapeutic areas including respiratory health, cardiovascular conditions, and gastrointestinal disorders. Notable offerings include Xuanfei Zhike granules and specialized Mongolian medicinal preparations. The organization integrates traditional knowledge with contemporary clinical research to develop proprietary formulations. By maintaining rigorous quality management systems and investing in automated production lines, the company aims to enhance the efficacy and accessibility of ethnic medicines for a broad patient base.

Recent filings

Filing Released Lang Actions
董事、监事减持股份进展公告
Director's Dealing Classification · 100% confidence The document is a public announcement regarding the progress of shareholding reduction by company directors and supervisors. It details the number of shares held before and after the reduction, the reduction plan's implementation progress, and risk disclosures related to the share reduction. There is no financial report, earnings data, or management discussion. The document fits the definition of a Director's Dealing report, which covers personal share transactions by company directors and executives (insider trades). The document length is short and focused solely on shareholding changes by insiders, confirming it is not a full financial report or other type of filing.
2022-05-23 Chinese
关于召开2022 年第二次临时股东大会通知公告（提供网络投票）
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a notice announcing the convening of the 2022 second extraordinary general meeting of shareholders for Inner Mongolia Datang Pharmaceutical Co., Ltd. It details the meeting date, voting methods, attendees, agenda items, and registration procedures. It does not contain any financial statements, audit results, or detailed financial data. It is not a report itself but an announcement about a shareholders' meeting. Therefore, it fits the category of a Proxy Solicitation & Information Statement (PSI), which includes materials sent to shareholders to provide information and request votes for meetings.
2022-05-22 Chinese
董事会议事规则
Governance Information Classification · 100% confidence The document is titled "内蒙古大唐药业股份有限公司董事会议事规则" which translates to "Inner Mongolia Datang Pharmaceutical Co., Ltd. Board Meeting Rules." It details the rules and procedures governing the board of directors' meetings, including composition, duties, meeting protocols, voting procedures, and responsibilities. The document is a formal governance document outlining internal rules for the board's operation. It is not a report of financial results, audit, or any announcement of voting results or management changes. It is clearly a governance-related document describing the company's internal board structure and governance practices. Therefore, the appropriate classification is Governance Information (CGR). The document length (over 12,000 characters) and detailed content confirm it is the actual governance document, not just an announcement or summary.
2022-05-22 Chinese
董事任命公告
Board/Management Information Classification · 95% confidence The document is an announcement regarding the appointment of a new director (粘立军) to the company's board. It details the nomination, approval by the board, and the qualifications of the new director. There is no financial data, earnings information, or report attached. The content focuses on board/management changes, specifically the appointment of a non-independent director. Therefore, this fits the category of Board/Management Information (MANG). The document length is short and it is not an announcement of a report publication or regulatory filing. Hence, the classification is MANG with high confidence.
2022-05-22 Chinese
独立董事关于第三届董事会第五次会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent directors' opinion on board meeting matters, specifically regarding the nomination of a non-independent director and the appointment of a deputy general manager. It references compliance with company law and listing rules, and it is a formal announcement of board/management changes. The document length is short (875 characters), and it contains no financial data or report content. Therefore, it is not an annual report, audit report, or financial report. It fits the category of Board/Management Information (MANG) as it announces changes in the company's board and senior management.
2022-05-22 Chinese
关于拟修订公司章程公告
Governance Information Classification · 95% confidence The document is an announcement regarding proposed amendments to the company's Articles of Association (公司章程). It details specific changes to governance provisions such as the composition and roles within the board of directors. There is no financial data, no mention of annual or interim reports, earnings, or other financial disclosures. The focus is on governance structure changes, specifically board composition and roles. This fits the category of Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices. The document length is short and it is not a report publication announcement or a regulatory filing. Therefore, the classification is Governance Information (CGR) with high confidence.
2022-05-22 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.